Low-cost PCR using asymmetric oligonucleotide primers that anneal to the CGG motif in FMR1 can screen individuals at high risk of FXS [35, 37, 111], and Southern blotting can be used as a confirmatory test [112]. This evidence concerns the gene FMR1 and fragile X syndrome.